Chronic lymphocytic leukaemia+2
Not yet recruitingComparison of rocbrutinib versus pirtobrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
Comparison of rocbrutinib versus pirtobrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
- Disease:Chronic lymphocytic leukaemiaChronic lymphocytic leukaemia refractory+1
- Substances:Pirtobrutinib
Czechia- Participants:18–64 years · 65+ years
- Substances:Pirtobrutinib
- Sponsor:Newave Pharmaceutical Inc.




